Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.3.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.2.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
JN.1.4.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
XDK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
unclassifiableEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
KR.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
MD.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
LF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
BQ.1.1.70NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
GW.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
CM.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.2.85NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.5.2.28NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.5.2.62NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.5.2.24NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.28NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.25NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.7.4.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.5.2.43NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.5.2.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.41NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.36NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BM.1.1.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.5.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
FM.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
GK.1.11.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
LB.1.7.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-3736.39Singapore
JN.1.18.7SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-3736.39Singapore
JN.1.42SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-3736.39Singapore
JN.1.39.2SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-3736.39Singapore
FL.20SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-3729.36Japan
BA.5.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-3717.85Germany
BA.2.53ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-3690.81Japan
EG.1.5ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-3690.81Japan
BA.5.5.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-3686.07Germany
CH.1.1.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-3686.07Germany
BA.2.18ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-3686.07Germany
BQ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
CH.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BF.7.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.4 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.5.5.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
CH.1.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
BA.2.75.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3680.15Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used